Advertisement
Experts believe this new stop-smoking product is important because itprovides smokers with a new option to quit smoking and the unique whiteningmay be an extra push to motivate smokers to initiate a quit attempt. In fact,the survey shows that 72 percent of people believe a quit-smoking product withteeth whitening benefits will encourage them so they can quit for good.(2)
Advertisement
"What is interesting about this survey is that while smokers arewell-aware of the health risks, appealing to their vanity may actually help topush them into action and to decide to quit," said Dr. Catrise Austin, founderand director of VIP Smiles in New York City and 'dentist to the stars.' "As acosmetic dentist, I've seen firsthand the impact smoking has on the appearanceand health of a person's teeth. I'm thrilled to have a new option to discusswith my patients. Nicorette White Ice Mint meets their unique needs bycontrolling cravings and whitening their teeth."
According to the survey, 42 percent of smokers are still trying to quit ontheir own without help.(2) Yet, smokers are twice as likely to be successfulif they use therapeutic nicotine rather than quitting cold turkey.(1)Nicorette White Ice Mint is specifically designed to relieve withdraw symptomsby safely and gradually reducing dependence on nicotine.(1) Nicorette WhiteIce Mint provides smokers with the help they need to end their smokingaddiction, and the product's whitening benefit can strengthen motivation.(2)
"Smoking is one of the most difficult addictions to break, and everysmoker is different -- in terms of their habits, triggers and what motivatesthem to quit," said Saul Shiffman, Ph.D., lead researcher and professor in thedepartments of psychology and pharmaceutical science at the University ofPittsburgh. "Anything that encourages a smoker to quit is a positive thing,but they need help to quit successfully. Nicorette White Ice Mint is a new,safe, effective option that helps smokers overcome difficult cravings and quitfor good."
Nicorette White Ice Mint is readily available over the counter without adoctor's prescription at more than 35,000 retail outlets, and can help reducewithdrawal symptoms commonly associated with quitting smoking.(3) Smokersinterested in quitting can visit http://www.Nicorette.com for more informationabout new Nicorette White Ice Mint.
Over-the-counter therapeutic nicotine products like Nicorette gum,NicoDerm CQ patch, and Commit lozenge are first-line treatments for smokingcessation and are thoroughly researched, well-understood and highly accessiblestop smoking therapies.(4) Unfortunately, the majority of smokers try to quitwith no assistance at all and only 3-5 percent of smokers who quit "coldturkey" are successfullong-term.(5)
About Nicorette
Nicorette is a stop-smoking aid which provides fast, safe, controlleddoses of nicotine to ease withdrawal from cigarettes. Convenient to carry anduse, Nicorette allows smokers to control how much nicotine they use, and givesthem the added flexibility of chewing an additional piece within the hour totreat strong or frequent cravings. Nicorette is sugar-free and available instrengths of 2mg (for smokers of less than 25 cigarettes each day) and 4mg(for smokers of 25 or more cigarettes each day) and also is available inexciting flavors such as Fresh Mint, Fruit Chill, and Cinnamon Surge.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largestover-the-counter consumer healthcare products companies. Its more than 30well-known brands include the leading smoking cessation products, Nicorette(R)and NicoDerm(R)CQ(R), and Commit(R), as well as many medicine cabinet staples-- alli(R), Aquafresh(R), Sensodyne(R), and TUMS(R) -- which are trademarksowned by and/or licensed to GlaxoSmithKline Group of Companies.
About GlaxoSmithKline
GlaxoSmithKline -- one of the world's leading research-basedpharmaceutical and healthcare companies -- is committed to improving thequality of human life by enabling people to do more, feel better and livelonger. For company information visit: http://www.gsk.com.(1) Silagy C, Stead LF, et. al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 1996, Issue 3. Art. No.: CD000146. DOI: 10.1002/14651858.CD000146.pub3. Available at: http://www.cochrane.org/reviews/en/ab000146.html (2) Survey of 327 smokers, Richard Day Research. September 2008. (3) GSK Data on file. (4) Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. May 2008. (5) Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. 2004 Addiction, 99, 29-38. Contacts: Mark Polisky, GolinHarris 312-729-4417 [email protected] Jennifer May, GlaxoSmithKline Consumer Healthcare 412-200-3729 [email protected]
SOURCE GlaxoSmithKline Consumer Healthcare